Sacubitril-valsartan (ARNI)

Are you sure? Dr. Taylor reminds you that therapy with an angiotensin receptor-neprilysin inhibitor (ARNI) is very beneficial for the treatment of chronic heart failure. Since Mrs. Reed was diagnosed with heart failure two years ago, she is likely already taking a drug that inhibits the RAAS pathway. The benefits of using an ARNI in the acute setting are not clear though. 

Since this is a virtual patient, you may go back and try again.

  • Furosemide (loop diuretic)

Map: Faith Reed_ORU (1088)
Node: 20511
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Omalizumab (IgE antibody)/Salbutamol (SABA)
  • History of Present Illness
  • Salbutamol (SABA)
  • Privacy risk
  • Opțiunea 1
  • Laboratory Safety
  • Decreased levels of HDL
  • Digoxin
  • LAB SAFETY
  • MICROSCOPIA ELECTRONICĂ
  • Lansoprazole, bismuth subsalicytate, metronidazole, and tetracycline
  • Decreased entry of glucose into muscle cells
  • Increased entry of fatty acids into adipocytes
  • Increased LDL uptake in hepatocytes
  • Наполягати на амбулаторному обстеженні та лікуванні.
  • Tele-Physical Examination
  • Αλληλόμορφα
  • Ethanol
  • Amplificarea ADN-ului
  • Digoxin (digitalis, positive inotropic drug)
  • Decreased absorption of dietary cholesterol
  • USING BASIC LABORATORY EQUIPMENT
  • Mechanism of action of GTN
  • Sacubitril-valsartan (ARNI)

Reminder

empty_reminder_msg

FINISH

Time is up